Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Flash call COVID-19

Date added:

Targeted on four priorities identified by the WHO : 1) epidemiological and translational studies; 2) the pathophysiology of the disease (not including vaccines); 3) infection prevention and control measures in the healthcare setting (including the

Amount
€3M
Agency or Funder
French Agence Nationale de la Recherche
Eligibility (if available)

Scientists from research institutes/organizations or company with French headquarters

Foreign participation? (where known)
No
Date application deadline

COVID-19 in haematology

Date added:

Proposals should address COVID-19 infection in malignant and benign haematologic disorders or haematological and immunological manifestations in COVID-19 infection.

Amount
€120.000
Agency or Funder
European Hematology Association
Eligibility (if available)

Home or host institute must be in Europe

Foreign participation? (where known)
Yes
Date application deadline

Research on clinical and community-related aspects of COVID-19

Date added:

Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19. Translational projects will be preferred. Basic research at the cellular level, or into animals, will not be considered.

Amount
$25,000 USD
Agency or Funder
CHEST Foundation
Eligibility (if available)

Health professionals, clinical researchers and non-profts that are members of CHEST

Foreign participation? (where known)
Yes
Date application deadline

Competitive revision and administrative supplements to clinical and translational awardees

Date added:

Additional support for current Clinical and Translational Science Award (CTSA) award recipients for digital health platforms, planning of COVID-19 trials and clinical study data.

Amount
Not limited
Agency or Funder
National Center for Advancing Translational Sciences
Eligibility (if available)

Clinical and Translational Science Award (CTSA) award recipients

Foreign participation? (where known)
No
Date application deadline